GlassScriptPhysician profile
Michael John Schmidling
NPI 1518942408
$2,536.48
in general payments reported to CMS, 2019-2025
14 companies · $75.00 in 2025
The $75.00 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $276 · 2021: $385 · 2022: $470 · 2023: $161 · 2024: $246 · 2025: $75.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461 · Grant: $20.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.22 |
| Grant | $20.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $589.07 | 2019-2024 | Embold Fibered, Ranger, Jetstream Sc |
| Abbott Laboratories | $580.72 | 2019-2023 | Jeti |
| Sirtex Medical INC | $416.14 | 2019-2022 | |
| Cardiovascular Systems INC. | $378.08 | 2019-2020 | |
| Veryan Medical Incorporated | $159.99 | 2022 | |
| Allergan, INC. | $149.85 | 2019 | |
| Terumo Medical Corporation | $75.00 | 2025 | Hydropearl, Azur Cx Detachable, Progreat |
| Medtronic USA, INC. | $42.06 | 2019 | |
| W. L. Gore & Associates, INC. | $33.52 | 2019-2020 | |
| Shockwave Medical, INC | $33.14 | 2020 | |
| Si-Bone, INC. | $23.98 | 2021-2022 | |
| Cook Medical LLC | $22.36 | 2019 | |
| Abbvie INC. | $20.84 | 2024 | |
| Medtronic, INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Schmidling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.